Professional Summary

Professional Overview

J Foulkes is a seasoned biopharmaceutical executive with over 30 years of industry experience. He currently serves as the CEO of Thirona Bio and Lipidio Pharmaceuticals, leading the strategic direction and day-to-day operations of these innovative life science companies.

Experience Summary

Current Roles

As the CEO of Thirona Bio since March 2020, J Foulkes is responsible for driving the company's mission to develop novel therapies for rare and orphan diseases. Under his leadership, Thirona Bio has made significant advancements in its clinical pipeline and secured key partnerships to accelerate its growth.

Concurrently, J Foulkes has served as the CEO of Lipidio Pharmaceuticals since January 2019. In this role, he has overseen the company's focus on developing cutting-edge lipid-based therapeutics, leveraging his deep expertise in this field to guide Lipidio's strategic initiatives and foster a culture of innovation.

Career Progression

Prior to his current roles, J Foulkes held several notable positions in the biopharmaceutical industry. He served as the CEO of Excaliard Pharmaceuticals, Inc. from 2010 to 2011 and as the CEO of Excalaird from 2007 to 2011. Additionally, he was the Managing Director at RiverVest Venture Partners from 2005 to 2010, where he played a key role in identifying and investing in promising life science startups.

Earlier in his career, J Foulkes held the positions of CTO at Aurora Biosciences from 1996 to 1998 and CSO at OSI Pharmaceuticals from 1986 to 1996. In these roles, he demonstrated his technical expertise and strategic vision, contributing to the development of innovative pharmaceutical products and shaping the direction of the companies he served.

Academic Background

J Foulkes holds a strong academic background, having completed his education in the field of life sciences. His specific educational qualifications and achievements are not provided in the given information.

Areas of Expertise

Throughout his distinguished career, J Foulkes has amassed a wealth of expertise in the biopharmaceutical industry, with a particular focus on rare and orphan diseases, as well as lipid-based therapeutics. He has demonstrated exceptional leadership and management skills, guiding companies through strategic initiatives and fostering a culture of innovation and growth.

Professional Impact

J Foulkes has left a notable impact on the biopharmaceutical industry through his contributions to the development of novel therapies and his involvement in driving the success of the companies he has led. His achievements and industry impact are not explicitly stated in the provided information.

Conclusion

With his extensive experience, technical expertise, and proven leadership abilities, J Foulkes continues to make significant contributions to the biopharmaceutical industry. As the CEO of Thirona Bio and Lipidio Pharmaceuticals, he is well-positioned to drive these companies' growth and deliver innovative solutions that address unmet medical needs.